Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc Stock

119.44P/E
€2.77BMarket capitalisation
-US$0.03Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Xeris Biopharma Holdings Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Xeris Biopharma Holdings Inc stock.

Market capitalisation
€2.77B
P/E
119.44
P/B
60.99
P/S
8.40
P/CF
40.90
Issued shares 183M Units

Return

Here you can see the performance of the Xeris Biopharma Holdings Inc stock.

PeriodPerfor­mance
1 Week+1.47 %
1 Month+63.96 %
3 Months+98.20 %
6 Months+185.48 %
1 Year+141.19 %
YTD+139.82 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Xeris Biopharma Holdings Inc share.

DateRatio
No data available.

Which ETF contains the Xeris Biopharma Holdings Inc stock?

The Xeris Biopharma Holdings Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Xeris Biopharma Holdings Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Xeris Biopharma Holdings Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.